These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16432489)

  • 21. An introduction to the endocannabinoid system: from the early to the latest concepts.
    De Petrocellis L; Di Marzo V
    Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):1-15. PubMed ID: 19285257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endocannabinoid signaling directs periimplantation events.
    Wang H; Xie H; Dey SK
    AAPS J; 2006; 8(2):E425-32. PubMed ID: 16808046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The endocannabinoid system and the control of glucose homeostasis.
    Nogueiras R; Rohner-Jeanrenaud F; Woods SC; Tschöp MH
    J Neuroendocrinol; 2008 May; 20 Suppl 1():147-51. PubMed ID: 18426514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endocannabinoids and liver disease. V. endocannabinoids as mediators of vascular and cardiac abnormalities in cirrhosis.
    Moezi L; Gaskari SA; Lee SS
    Am J Physiol Gastrointest Liver Physiol; 2008 Oct; 295(4):G649-53. PubMed ID: 18703639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Endocannabinoid system and energy metabolism: physiology and pathophysiology].
    Pagotto U; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):74S-82S. PubMed ID: 18773754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocannabinoids and immune regulation.
    Pandey R; Mousawy K; Nagarkatti M; Nagarkatti P
    Pharmacol Res; 2009 Aug; 60(2):85-92. PubMed ID: 19428268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract.
    Massa F; Storr M; Lutz B
    J Mol Med (Berl); 2005 Dec; 83(12):944-54. PubMed ID: 16133420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endocannabinoids and liver disease. II. Endocannabinoids in the pathogenesis and treatment of liver fibrosis.
    Siegmund SV; Schwabe RF
    Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G357-62. PubMed ID: 18006606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabinoids and the gut: new developments and emerging concepts.
    Izzo AA; Sharkey KA
    Pharmacol Ther; 2010 Apr; 126(1):21-38. PubMed ID: 20117132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of endocannabinoids on cardiovascular system].
    Ma SY; Ma YX
    Sheng Li Ke Xue Jin Zhan; 2006 Oct; 37(4):297-301. PubMed ID: 17262961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The endocannabinoid-CB receptor system: Importance for development and in pediatric disease.
    Fride E
    Neuro Endocrinol Lett; 2004; 25(1-2):24-30. PubMed ID: 15159678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mechanisms of endocannabinoid-mediated retrograde modulation of synaptic transmission].
    Tanimura A; Hashimotodani Y; Kano M
    Seikagaku; 2011 Aug; 83(8):704-14. PubMed ID: 21942092
    [No Abstract]   [Full Text] [Related]  

  • 33. The Endocannabinoid System in the Retina: From Physiology to Practical and Therapeutic Applications.
    Schwitzer T; Schwan R; Angioi-Duprez K; Giersch A; Laprevote V
    Neural Plast; 2016; 2016():2916732. PubMed ID: 26881099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endocannabinoids and liver disease. III. Endocannabinoid effects on immune cells: implications for inflammatory liver diseases.
    Pacher P; Gao B
    Am J Physiol Gastrointest Liver Physiol; 2008 Apr; 294(4):G850-4. PubMed ID: 18239059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of the endocannabinoid system in the development of tolerance to alcohol.
    Basavarajappa BS; Hungund BL
    Alcohol Alcohol; 2005; 40(1):15-24. PubMed ID: 15550443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-ischemic brain damage: the endocannabinoid system in the mechanisms of neuronal death.
    Pellegrini-Giampietro DE; Mannaioni G; Bagetta G
    FEBS J; 2009 Jan; 276(1):2-12. PubMed ID: 19087195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabinoid receptors as therapeutic targets.
    Mackie K
    Annu Rev Pharmacol Toxicol; 2006; 46():101-22. PubMed ID: 16402900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Functional role of the endocannabinoid system in emotional homeostasis].
    Marco EM; Viveros MP
    Rev Neurol; 2009 Jan 1-15; 48(1):20-6. PubMed ID: 19145562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocannabinoids in liver disease and hepatic encephalopathy.
    Magen I; Avraham Y; Berry E; Mechoulam R
    Curr Pharm Des; 2008; 14(23):2362-9. PubMed ID: 18781986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The endocannabinoid system and the regulation of neural development: potential implications in psychiatric disorders.
    Galve-Roperh I; Palazuelos J; Aguado T; Guzmán M
    Eur Arch Psychiatry Clin Neurosci; 2009 Oct; 259(7):371-82. PubMed ID: 19588184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.